Clinical Trials Directory

TUPKRP Combined With MAB Therapy for LUTS/PCa

Prospective Observational Trial to Evaluate Quality of Life After Definitive Chemoradiation in Patients With Anal Cancer (LANACARE)

The Bern Heart and Brain Interaction Study - Interaction Between Brain and Heart in Acute Ischemic Stroke

HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

Intuitive Control of a Hybrid Prosthetic Leg During Ambulation

Oxycodone and Sufentanil for Analgesia in Hip Surgery

Pro-active Fecal Calprotectin Monitoring PROMOTE-UC

First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer

Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure

TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors

Canadian SCAD Study

Outcomes Mandate National Integration With Cannabis as Medicine

NOVOCART 3D Treatment Following Microfracture Failure

Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial

Effectiveness of Environmental Measures to Eliminate the Risks of Lead Exposure in Infant Lead Poisoning

Parent and Infant Inter(X)Action Intervention (PIXI)

Peer Approaches to Lupus Self-management

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

A Randomized Phase 2 Study of Cemiplimab ± ISA101b in HPV16-Positive OPC

Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis

TReatment of Pulmonary Hypertension Group II Study

Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative Chemotherapy

Genetic Information to Inform Treatment and Screening for Prostate Cancer, GIFTS Study

A Global Study to Evaluate Transarterial Chemoembolization (TACE) in Combination With Durvalumab and Bevacizumab Therapy in Patients With Locoregional Hepatocellular Carcinoma

Feasibility Study of MET-4: Evaluating Fecal Microbiome Effects in Immunotherapy Patients

Walking Rehabilitation After Spinal Cord Injury: Locomotor Training Using Adaptive Robotics

Paricalcitol Addition to Chemotherapy in Patients With Previously Untreated Metastatic Pancreatic Ductal Adenocarcinoma

De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas

GISAR German Interdisciplinary Sarcoma Registry

Cognitive Behavioral Therapy in Helping Patients With Acute Myeloid Leukemia or Lymphoma With Cancer-Related Fatigue

Neoadjuvant CCRT With Gemcitabine/Durvalumab (MEDI4736) Followed by Adjuvant Gemcitabine/Durvalumab(MEDI4736) in Resectable or Borderline Resectable Pancreatic Cancer

Atezolizumab and Cobimetinib in Treating Patients With Metastatic, Recurrent, or Refractory Non-small Cell Lung Cancer

Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma

Venetoclax and Azacitidine for Non-Elderly Adult Patients With Acute Myeloid Leukemia

IRIS- DESyne X2 in the IRIS-DES Registry

alloSHRINK - Standard cHemotherapy Regimen and Immunotherapy With Allogeneic NKG2D-based CYAD-101 Chimeric Antigen Receptor T-cells

Post-Authorization Long-Term Safety Study of LUTATHERA

Vaginal Microbiome Exposure and Immune Responses in C-section Infants

CD19-specific CAR T Cells With a Fully Human Binding Domain for CD19+ Leukemia or Lymphoma

Aquaporin-4 Single Nucleotide Polymorphisms in Patients With Idiopathic and Familial Parkinson's Disease

Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma

A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).

Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors

Anamorelin Hydrochloride in Reducing Anorexia in Patients With Advanced Non-small Cell Lung Cancer

Perioperative Management Evaluation in Patients With CIED

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Pyloroplasty Versus No Pyloroplasty in Patients Undergoing Esophagectomy

Validation of a Novel Smartphone-based Method for Heart Rhythm Monitoring in the Home Environment

Ipilumumab and Nivolumab With or Without Hypofractionated Radiotherapy in Patients With Metastatic Melanoma

Preventing Asthma in High Risk Kids